Identification of Human Host Substrates of the SARS-CoV-2 M<sup>pro</sup> and PL<sup>pro</sup> Using Subtiligase N-Terminomics-Reference-Cited by-同舟云学术

Identification of Human Host Substrates of the SARS-CoV-2 M^pro and PL^pro Using Subtiligase N-Terminomics

Published:2023-04-03 Issue:4 Volume:9 Page:749-761
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Luo Shu Y.¹,Moussa Eman W.¹,Lopez-Orozco Joaquin²,Felix-Lopez Alberto³,Ishida Ray³,Fayad Nawell²,Gomez-Cardona Erik¹,Wang Henry¹^ORCID,Wilson Joyce A.⁴,Kumar Anil⁴^ORCID,Hobman Tom C.²³⁵,Julien Olivier¹⁵^ORCID

Affiliation:

1. Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada

2. Department of Cell Biology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada

3. Department of Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta T6G 2H7, Canada

4. Department of Biochemistry, Microbiology & Immunology, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada

5. Li Ka Shing Institute of Virology, Edmonton, Alberta T6G 2E1, Canada

Funder

Institute of Infection and Immunity

University of Alberta

Natural Sciences and Engineering Research Council of Canada

Tonix Pharmaceuticals

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.2c00458

Reference63 articles.

1. The SARS-CoV-2 main protease as drug target

2. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

3. A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CLpro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19

4. Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

5. An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural review of SARS-CoV-2 antiviral targets;Structure;2024-09

2. SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2;Journal of Cell Science;2024-05-15

3. Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease;Journal of Virology;2024-05-14

4. Data-Independent Acquisition Proteomics and N-Terminomics Methods Reveal Alterations in Mitochondrial Function and Metabolism in Ischemic-Reperfused Hearts;Journal of Proteome Research;2024-01-24

5. Application of N-Terminal Labeling Methods Provide Novel Insights into Endoproteolysis of the Prion Protein in Vivo;ACS Chemical Neuroscience;2023-12-14